Mir-338-3p targeting THBS1 attenuates glioma progression by inhibiting the PI3K/Akt pathway
Abstract Background Glioma is a brain tumor with high morbidity and mortality rates.Understanding its molecular pathogenesis can provide targets and therapeutic strategies for glioma treatment.miR-338-3p represses tumor growth in several cancers, including glioma.Thus, this study aimed to identify the regulatory effects Side Rails of miR-338-3p/pho